BioCentury | Oct 28, 2020
Finance

Oct. 27 Financial Quick Takes: Apellis-Sobi deal for C3 inhibitor; plus Primmune, Prokarium, Novartis-RegenxBio, Turning Point, Psyomics, Journey Colab

...Investment Partners led the round, which also saw participation from the U.K. government’s Future Fund, Flerie Invest...
BioCentury | Mar 4, 2020
Finance

March 3 Quick Takes: Megarounds for Akouos, Element; plus venture rounds by Kahr, Primmune, Lipidio and Scipio and more

...Signaling Proteins platform, the molecule targets SIRPA and 4-1BBL to treat solid tumors. Investors include Flerie Invest...
BioCentury | Oct 17, 2019
Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

...SVac, its Simian Virus 40-based gene delivery vector platform, to the clinic within three years. Flerie Invest...
BioCentury | Dec 2, 2016
Financial News

OxThera completes venture financing

...€32 million ($34.1 million) in a round co-led by LSP, Ysios Capital, Sunstone Capital and Flerie Invest...
BioCentury | Dec 1, 2016
Financial News

OxThera raises EUR 32M

...32 million ($34.1 million) in a round co-led by LSP, Ysios Capital, Sunstone Capital and Flerie Invest...
BioCentury | Dec 21, 2015
Financial News

Kahr Medical completes venture financing

...Venture financing Raised: $12 million Investors: Korea Investment Partners; Mirae Asset Venture Investment; DSC Investment; Flerie Invest...
Items per page:
1 - 6 of 6
BioCentury | Oct 28, 2020
Finance

Oct. 27 Financial Quick Takes: Apellis-Sobi deal for C3 inhibitor; plus Primmune, Prokarium, Novartis-RegenxBio, Turning Point, Psyomics, Journey Colab

...Investment Partners led the round, which also saw participation from the U.K. government’s Future Fund, Flerie Invest...
BioCentury | Mar 4, 2020
Finance

March 3 Quick Takes: Megarounds for Akouos, Element; plus venture rounds by Kahr, Primmune, Lipidio and Scipio and more

...Signaling Proteins platform, the molecule targets SIRPA and 4-1BBL to treat solid tumors. Investors include Flerie Invest...
BioCentury | Oct 17, 2019
Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

...SVac, its Simian Virus 40-based gene delivery vector platform, to the clinic within three years. Flerie Invest...
BioCentury | Dec 2, 2016
Financial News

OxThera completes venture financing

...€32 million ($34.1 million) in a round co-led by LSP, Ysios Capital, Sunstone Capital and Flerie Invest...
BioCentury | Dec 1, 2016
Financial News

OxThera raises EUR 32M

...32 million ($34.1 million) in a round co-led by LSP, Ysios Capital, Sunstone Capital and Flerie Invest...
BioCentury | Dec 21, 2015
Financial News

Kahr Medical completes venture financing

...Venture financing Raised: $12 million Investors: Korea Investment Partners; Mirae Asset Venture Investment; DSC Investment; Flerie Invest...
Items per page:
1 - 6 of 6